About
13,916.00GBX-90.00 -0.64%
Live at 20:37 GMT+00:00Market Cap$289.82B
P/E Ratio28.04
Volume1.04M
Beta1.29
RSI48.66
Gross Margin74.31%
Astrazeneca Plc — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026
May 18 2026
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
May 18 2026
AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer
May 14 2026
Imfinzi + EV improves EFS & OS in bladder cancer
May 1 2026
FDA ODAC vote on camizestrant in breast cancer
Community Chat
Ask AI
Try asking
Translate